Jiawei Ye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiawei Ye has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jun Zhang
Key Laboratory of Green Chemical Process of Ministry of Education, Key Laboratory of Novel Reactor and Green Chemical Technology of Hubei Province, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, P. R. China
4 shared publications Tielin Wang
State Key Laboratory of Green and Efficient Development of Phosphorus Resources, Key Laboratory of Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology Wuhan P. R. China
4 shared publicationsDesen Zhou
3 shared publicationsYucheng Feng
State Key Laboratory of Green and Efficient Development of Phosphorus Resources, Key Laboratory of Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology Wuhan P. R. China
3 shared publicationsJun Zhang
2 shared publicationsJuntao Zhao
State Key Laboratory of Green and Efficient Development of Phosphorus Resources, Key Laboratory of Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy
2 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Wiley in Chemphyschem
- Vol. 27 (14) , e70515
Zinc Tetrakis (4‐Carboxyphenyl) Porphyrin Intercalation Modification in CoAl‐Layered Double Hydroxides for Efficient Photocatalytic Reduction of CO 2
In order to enhance the light absorption capacity and promote the interlayer electron transport of CoAl‐layered double hydroxides (CoAl‐LDHs), a composite material of Zinc tetrakis (4‐carboxyphenyl) porphyrin (ZnTCPP) intercalated into CoAl‐LDHs interlayer was prepared by the exfoliation and re‐stacking method. The optimized composite exhibited excellent performance toward photocatalytic CO 2 reduction to CO, with an average CO evolution rate of 57.2 μmol·g −1 ·h −1 , which was 5.84 times and 2.87 times higher than those of pristine CoAl‐LDHs (9.8 μmol·g −1 ·h −1 ) and ZnTCPP (19.9 μmol·g −1 ·h −1 ), respectively. It is found that the intercalated ZnTCPP in CoAl‐LDHs could greatly improve the light absorption capacity and promote the interlayer electron transport, resulting in high photocatalytic CO 2 reduction performance.
- 20 July 2026
- Published by Wiley in Chemphyschem
- Vol. 27 (14) , e70515
Open AccessZinc Tetrakis (4‐Carboxyphenyl) Porphyrin Intercalation Modification in CoAl‐Layered Double Hydroxides for Efficient Photocatalytic Reduction of CO 2
In order to enhance the light absorption capacity and promote the interlayer electron transport of CoAl‐layered double hydroxides (CoAl‐LDHs), a composite material of Zinc tetrakis (4‐carboxyphenyl) porphyrin (ZnTCPP) intercalated into CoAl‐LDHs interlayer was prepared by the exfoliation and re‐stacking method. The optimized composite exhibited excellent performance toward photocatalytic CO 2 reduction to CO, with an average CO evolution rate of 57.2 μmol·g −1 ·h −1 , which was 5.84 times and 2.87 times higher than those of pristine CoAl‐LDHs (9.8 μmol·g −1 ·h −1 ) and ZnTCPP (19.9 μmol·g −1 ·h −1 ), respectively. It is found that the intercalated ZnTCPP in CoAl‐LDHs could greatly improve the light absorption capacity and promote the interlayer electron transport, resulting in high photocatalytic CO 2 reduction performance.
- Open Access
- 20 February 2026
- Published by Elsevier in SSRN Electronic Journal
Intramolecular Hydrogen Bond-Promoted N2 Activation in Hydroxyl-Functionalized Fe-MOFs for Efficient Photocatalytic Ammonia Synthesis
Photocatalytic nitrogen reduction offers a novel approach for the green utilization of nitrogen gas by converting N2 into ammonia while addressing the energy crisis. Metal-organic frameworks (MOFs) have sparked intense research interest in photocatalysis due to their structural and functional designability alongside broad light-harvesting capabilities. However, the role of specific functional groups on building blocks and their effect on the catalytic performance of MOFs are ambiguous. In this study, three Fe-MOFs with varing hydroxyl group contents were designed and fabricated. It was found that the Fe-MOFs functionalized with two meta-positioned hydroxyl ligands (2,6-Fe-MOF) exhibited significantly superior photocatalytic performance for ammonia synthesis through N2 fixation. Experimental and theoretical investigations revealed that the formation of intramolecular hydrogen bonds can induce longer Fe–O bonds with higher electron density at the Fe centers. Consequently, enhanced back-donation interactions occur between the Fe centers and the π* orbitals of N2 molecules, leading to their activation. Precise modulation of hydroxyl groups and intramolecular hydrogen bonds serves as a key role in boosting the photocatalytic N2 fixation activity of Fe-MOFs, providing important insights into the rational design of efficient photocatalysts.
- 20 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIntramolecular Hydrogen Bond-Promoted N2 Activation in Hydroxyl-Functionalized Fe-MOFs for Efficient Photocatalytic Ammonia Synthesis
Photocatalytic nitrogen reduction offers a novel approach for the green utilization of nitrogen gas by converting N2 into ammonia while addressing the energy crisis. Metal-organic frameworks (MOFs) have sparked intense research interest in photocatalysis due to their structural and functional designability alongside broad light-harvesting capabilities. However, the role of specific functional groups on building blocks and their effect on the catalytic performance of MOFs are ambiguous. In this study, three Fe-MOFs with varing hydroxyl group contents were designed and fabricated. It was found that the Fe-MOFs functionalized with two meta-positioned hydroxyl ligands (2,6-Fe-MOF) exhibited significantly superior photocatalytic performance for ammonia synthesis through N2 fixation. Experimental and theoretical investigations revealed that the formation of intramolecular hydrogen bonds can induce longer Fe–O bonds with higher electron density at the Fe centers. Consequently, enhanced back-donation interactions occur between the Fe centers and the π* orbitals of N2 molecules, leading to their activation. Precise modulation of hydroxyl groups and intramolecular hydrogen bonds serves as a key role in boosting the photocatalytic N2 fixation activity of Fe-MOFs, providing important insights into the rational design of efficient photocatalysts.
- 11 February 2026
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 65 (7) , 3886-3894
Construction of 0D/2D Porphyrin-Based MOF-on-MOF Heterojunctions for Efficient Photocatalytic CO 2 Reduction
- 11 February 2026
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 65 (7) , 3886-3894
Construction of 0D/2D Porphyrin-Based MOF-on-MOF Heterojunctions for Efficient Photocatalytic CO 2 Reduction
- 1 March 2025
- Published by Elsevier in Acta Physico-Chimica Sinica
- Vol. 41 (7)
Modulating the d-band center of NNU-55(Fe) for enhanced CO2 adsorption and photocatalytic activity
- 1 March 2025
- Published by Elsevier in Acta Physico-Chimica Sinica
- Vol. 41 (7)
Modulating the d-band center of NNU-55(Fe) for enhanced CO2 adsorption and photocatalytic activity
- 15 March 2023
- Published by Elsevier in Applied Surface Science
- Vol. 623
Hierarchical Pt/NiCo2O4 nanosheets decorated carbon nanofibers for room-temperature catalytic formaldehyde oxidation
- 15 March 2023
- Published by Elsevier in Applied Surface Science
- Vol. 623
Hierarchical Pt/NiCo2O4 nanosheets decorated carbon nanofibers for room-temperature catalytic formaldehyde oxidation
- Open Access
- 31 August 2022
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 34 (1) , 92-102
Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
Cancer patients often suffer from cancer symptoms, treatment complications and concomitant diseases and are, therefore, often treated with several drugs in addition to anticancer drugs. Whether such drugs, here denoted as ‘concomitant drugs’, have anticancer effects or interact at the tumor cell level with the anticancer drugs is not very well known. The cytotoxic effects of nine concomitant drugs and their interactions with five anti-cancer drugs commonly used for the treatment of colorectal cancer were screened over broad ranges of drug concentrations in vitro in the human colon cancer cell line HCT116wt. Seven additional tyrosine kinase inhibitors were included to further evaluate key findings as were primary cultures of tumor cells from patients with colorectal cancer. Cytotoxic effects were evaluated using the fluorometric microculture cytotoxicity assay (FMCA) and interaction analysis was based on Bliss independent interaction analysis. Simvastatin and loperamide, included here as an opioid agonists, were found to have cytotoxic effects on their own at reasonably low concentrations whereas betamethasone, enalapril, ibuprofen, metformin, metoclopramide, metoprolol and paracetamol were inactive also at very high concentrations. Drug interactions ranged from antagonistic to synergistic over the concentrations tested with a more homogenous pattern of synergy between simvastatin and protein kinase inhibitors in HCT116wt cells. Commonly used concomitant drugs are mostly neither expected to have anticancer effects nor to interact significantly with anticancer drugs frequently used for the treatment of colorectal cancer.
- 31 August 2022
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 34 (1) , 92-102
Open AccessAssessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
Cancer patients often suffer from cancer symptoms, treatment complications and concomitant diseases and are, therefore, often treated with several drugs in addition to anticancer drugs. Whether such drugs, here denoted as ‘concomitant drugs’, have anticancer effects or interact at the tumor cell level with the anticancer drugs is not very well known. The cytotoxic effects of nine concomitant drugs and their interactions with five anti-cancer drugs commonly used for the treatment of colorectal cancer were screened over broad ranges of drug concentrations in vitro in the human colon cancer cell line HCT116wt. Seven additional tyrosine kinase inhibitors were included to further evaluate key findings as were primary cultures of tumor cells from patients with colorectal cancer. Cytotoxic effects were evaluated using the fluorometric microculture cytotoxicity assay (FMCA) and interaction analysis was based on Bliss independent interaction analysis. Simvastatin and loperamide, included here as an opioid agonists, were found to have cytotoxic effects on their own at reasonably low concentrations whereas betamethasone, enalapril, ibuprofen, metformin, metoclopramide, metoprolol and paracetamol were inactive also at very high concentrations. Drug interactions ranged from antagonistic to synergistic over the concentrations tested with a more homogenous pattern of synergy between simvastatin and protein kinase inhibitors in HCT116wt cells. Commonly used concomitant drugs are mostly neither expected to have anticancer effects nor to interact significantly with anticancer drugs frequently used for the treatment of colorectal cancer.